TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 6th day of June, 2016, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Kenneth S. Parks (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
This Executive Employment Agreement (the “Agreement”) is dated as of June 6, 2016, by and between Mylan Inc. (the “Company” or “Mylan”) and Kenneth S. Parks (“Executive”).
AMENDMENT NO. 1 TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENTReceivables Purchase Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT, dated as of May 20, 2016 (this “Amendment”), is among MYLAN PHARMACEUTICALS INC. (“MPI”), individually and as initial servicer (in such capacity, the “Servicer”), MYLAN SECURITIZATION LLC (“Seller”), VICTORY RECEIVABLES CORPORATION (“Victory”), as a conduit purchaser (in such capacity, the “Conduit Purchaser”), PNC BANK, NATIONAL ASSOCIATION (“PNC”), as a committed purchaser, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH (“BTMUNY”), as a committed purchaser (each of PNC and BTMUNY in the capacity of a committed purchaser, individually, a “Committed Purchaser” and collectively, the “Committed Purchasers” and collectively with the Conduit Purchaser, the “Purchasers”), PNC, as a purchaser agent, BTMUNY, as a purchaser agent (each of PNC and BTMUNY in the capacity of a purchaser agent, individually, a “Purchaser Agent” and collectively, the “Purchaser Agents”), BTMUNY, as agent on behalf of the Secured P
RETIREMENT AND CONSULTING AGREEMENTRetirement and Consulting Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
This Retirement and Consulting Agreement (“Agreement”) is made by and between John D. Sheehan (“Sheehan”) and Mylan Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
Reference is made to the Third Amended and Restated Executive Employment Agreement, effective as of January 1, 2014 (the “Employment Agreement”), between Robert J. Coury (“Chairman”) and Mylan Inc. (“Mylan US”). Capitalized terms used but not defined...Award Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • New York
This letter agreement shall be effective as of the date first written above (the “Effective Date”) and shall terminate at the close of business on the fifth anniversary of the Transition Date (“Initial Term”), unless earlier terminated in accordance with the terms of this letter agreement or extended by mutual agreement of Mylan NV and Chairman.
